Association of PNPLA3 with non-alcoholic fatty liver disease in a minority cohort: the Insulin Resistance Atherosclerosis Family Study
about
Genetic background in nonalcoholic fatty liver disease: A comprehensive reviewComposite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countriesDefinitions of Normal Liver Fat and the Association of Insulin Sensitivity with Acquired and Genetic NAFLD-A Systematic ReviewBurden of hepatocellular carcinoma among hispanics in South Texas: a systematic review.Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey.NAFLD prevalence differs among hispanic subgroups: the Multi-Ethnic Study of Atherosclerosis.The association of inflammatory and fibrinolytic proteins with 5 year change in insulin clearance: the Insulin Resistance Atherosclerosis Study (IRAS)Gender and racial differences in nonalcoholic fatty liver disease.Pooled genetic analysis in ultrasound measured non-alcoholic fatty liver disease in Indian subjects: A pilot study.Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis.Genetic variants in PNPLA3 and risk of non-alcoholic fatty liver disease in a Han Chinese population.PNPLA3 I148M variant in nonalcoholic fatty liver disease: demographic and ethnic characteristics and the role of the variant in nonalcoholic fatty liver fibrosisPNPLA3 I148M polymorphism, clinical presentation, and survival in patients with hepatocellular carcinomaThe metabolically benign and malignant fatty liver.Association of PNPLA3 SNP rs738409 with liver density in African Americans with type 2 diabetes mellitusEthnicity and nonalcoholic fatty liver diseaseEstimating hepatic glucokinase activity using a simple model of lactate kinetics.PNPLA3 gene-by-visceral adipose tissue volume interaction and the pathogenesis of fatty liver disease: the NHLBI family heart studyInsulin clearance and the incidence of type 2 diabetes in Hispanics and African Americans: the IRAS Family StudyRacial differences in nonalcoholic fatty liver disease in the U.S. populationCharacterization of European ancestry nonalcoholic fatty liver disease-associated variants in individuals of African and Hispanic descent.Identification of combined genetic determinants of liver stiffness within the SREBP1c-PNPLA3 pathway.Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease.The impact of genetic variability on liver disease in the Hispanic/Latin-American population.Epidemiology of NAFLD and Type 2 Diabetes: Health Disparities Among Persons of Hispanic Origin.PNPLA3 as a Genetic Determinant of Risk for and Severity of Non-alcoholic Fatty Liver Disease Spectrum.Analysis of Whole Exome Sequencing with Cardiometabolic Traits Using Family-Based Linkage and Association in the IRAS Family Study.Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: The multiethnic cohort.Ethnicity predicts metabolic syndrome after liver transplant.Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis.Arsenic exposure and risk of nonalcoholic fatty liver disease (NAFLD) among U.S. adolescents and adults: an association modified by race/ethnicity, NHANES 2005-2014.Hispanic health in the USA: a scoping review of the literature.Managing the Burden of Non-NASH NAFLD.
P2860
Q26780248-6D224FA0-06F5-42D5-B5FD-4199E0824D48Q26828855-BA7792FB-22F1-4FAD-BE52-757B139753AAQ28070408-97DAC850-E9AE-4458-A5A9-8D4AFE56BCD5Q30234676-FFF00E57-9515-4B3D-800B-AEB6F1D616EBQ30589720-A1ABBD60-787B-4D93-AA4C-3884639A1DF1Q33564139-2A2EFBC2-3EA4-4FDD-B679-05DB54B6940CQ33567573-BCD05E7E-2FA6-49A9-B662-28BC3BE8CE57Q33660001-0BF7EDA9-68EB-4748-8230-1B579A6A7C58Q33845164-A1C2F788-B4E7-458F-8534-C9F757833B92Q34056163-57A6F6D9-59FB-4545-A4A5-74043DC2828AQ34505214-5B43EFDD-93CA-4A90-8537-AB28D1A5B65CQ34985968-7F54BA00-B5F6-411E-B09B-8A28E9561333Q35025215-5F7B64E4-A9A6-4F61-9587-DE4182218398Q35123495-3C6390A2-5A43-43B5-BBBC-F6539E47FCE0Q35549681-CA47E32B-5929-41B1-BF9E-1440FD53E891Q35754063-3E83338E-EC6E-407D-AC87-1D6D32523D79Q35898249-0A077DDE-8D0E-4D0C-B756-5E8F00E22940Q36137220-42B6DB89-7D44-4F07-9556-C00C60739C81Q36720325-56C553DF-AF18-4430-8620-81EA02DD417CQ36948248-D378AD5F-B1A3-44AA-ABEC-76A23CA3A1F9Q37197345-101750BB-0545-4D61-A2AE-C0AE23D5FE86Q37291432-3F0B2AAF-54E2-4E60-86C9-65204C2B6173Q37850396-600B917D-3AFC-4294-8F4C-263508F0E7F9Q37921758-BE0D78EF-8EE3-443A-B63B-324F637C06EAQ38607500-BEC3A438-CC0C-47F5-88FD-5F817269E245Q38989953-B945E9BC-3C08-4945-AAF5-D5CEE56BD9F1Q39032260-117A30C5-F6C1-4F46-B580-54C068A454CFQ40701165-6FED172A-C13D-4173-B873-54CFE5EA25A8Q40707126-4C4E3D70-34D3-4FD9-A57C-E3BAD69D5885Q47880294-201E128B-743D-4A23-9E86-86E340509BD4Q49193626-2FD86890-B62B-420C-A241-9B6CA00FF00DQ49954571-D9ECAC64-4D61-41D3-8FEC-2DE4546E995BQ53704720-3CC2CE90-015E-45C5-B221-A48C3C27982B
P2860
Association of PNPLA3 with non-alcoholic fatty liver disease in a minority cohort: the Insulin Resistance Atherosclerosis Family Study
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Association of PNPLA3 with non ...... e Atherosclerosis Family Study
@en
type
label
Association of PNPLA3 with non ...... e Atherosclerosis Family Study
@en
prefLabel
Association of PNPLA3 with non ...... e Atherosclerosis Family Study
@en
P2093
P2860
P1433
P1476
Association of PNPLA3 with non ...... e Atherosclerosis Family Study
@en
P2093
Ann Scherzinger
Carl D Langefeld
Donald W Bowden
Jill M Norris
Julie Ziegler
Nicholette D Palmer
Steven Haffner
Yii-Der I Chen
P2860
P304
P356
10.1111/J.1478-3231.2010.02444.X
P577
2011-01-13T00:00:00Z